| Test | Method | Limit | Result |
|---|---|---|---|
| Purity | HPLC | ≥ 99.0% | 99.23% |
| Identity | Mass spectrometry | Each component | All confirmed |
| Net content | Quantitative HPLC | ≥ 17.5 mg | 17.86 mg |
| Endotoxin | LAL assay | ≤ 0.5 EU/mg | 0.07 EU/mg |
| Sterility | Membrane filtration | No growth | No growth |
| Heavy metals | ICP-MS | ≤ 10 ppm total | 0.6 ppm |
| Moisture | Karl Fischer | ≤ 8.0% | 2.4% |
Three-compound blend: GLP-3 10 mg + Tesa 5 mg + Cagri 2.5 mg
Per component
3-compound blend
Each component is confirmed separately on the lot certificate.
Metabolic · Three-compound blend: GLP-3 10 mg + Tesa 5 mg + Cagri 2.5 mg
10 / 5 / 2.5 mg · 3-compound blend
Size$8.86/mg
Quantity10+ of one compound: 40% off
Same-day dispatch on orders by 2 PM ET, Monday to Friday
Arrives in 2 business days, tracked
Free shipping over $150
Earn Research Credit on top of your discount. VIP earns 3x more.
For in-vitro research use only. Not for human or animal use.
Metabolic
GLP-3 RT 5 mgMetabolic
GLP-2 TZ 10 mgMetabolic
5-Amino-1MQ 50 mgMetabolic
GLP-1 S 20 mgMetabolic
Cagri 10 mgMetabolic
GLP-3 / Cagri 10 / 2 mgMetabolic
GLP-2 / GLP-3 10 / 10 mgMetabolic
GLP-2 / Cagri 5 / 5 mgMetabolic
Cagri / GLP-1 5 / 5 mgTissue + immune
BPC-157 10 mgTissue + immune
TB-500 10 mgCopper peptides
GHK-Cu 50 mg01Verified test results
GLP-3 / Tesa / Cagri lot SA-GL1-2610 was tested Oct 8, 2026 at an independent laboratory before it shipped. Every value is printed against its limit, so a pass means something.
Certificate of analysis
99.23%
Purity by HPLC
Profile drawn from the reported purity
Purity by HPLC, identity by mass spectrometry, net content by quantitative HPLC, endotoxin by LAL, sterility by membrane filtration, heavy metals by ICP-MS and moisture by Karl Fischer. Report SA-GL1-2610-01, Oct 8, 2026. Open the lot record.
Open any lot's certificate. Your order ships from the current released lot, and its QR code opens this record.
99.23%
HPLC purity
Tested Oct 8, 2026 · 7/7 assays · sample
99.22%
HPLC purity
Tested Sep 10, 2026 · 7/7 assays · sample
02Verify your vial
Every vial label carries a QR code. Point your phone camera at it.
The code opens that lot's certificate with every assay value. No phone? Type the lot from your packing slip on Verify a lot.
Each signed certificate links to the lab's own verification page, so the report can be confirmed independently of us.
03Analytical identity
Studied in metabolic receptor-signalling models in vitro.
| Compound | Three-compound blend: GLP-3 10 mg + Tesa 5 mg + Cagri 2.5 mg |
|---|---|
| Formula | Per component |
| Molecular weight | Per component |
| Type | 3 compounds |
| Form | Lyophilised powder, 10 / 5 / 2.5 mg |
| Storage | Sealed at -20 °C, away from light and moisture |
Components
Each component is confirmed separately on the lot certificate.
04In the lab
GLP-3 RT, Tesamorelin and Cagri are each studied on their own pathways in laboratory research. This blend combines them in one vial; the map shows the best-characterized pathway reported for each.
Blend
GLP-3 / Tesa / CagriBlend of GLP-3 RT, Tesamorelin and CagriFat tissue remodeling
Endpoint studied
Lower lipogenesis, more fatty acid oxidation and mitochondrial function, less inflammatory and fibrotic signaling.
Li 2026 · PMID 41964043GH axis activation
Endpoint studied
Resisted DPP-IV, degraded more slowly in plasma than hGRF(1-44), and repeat runs raised GH and IGF-1.
Ferdinandi 2007 · PMID 17214611Dual receptor binding
Endpoint studied
Cryo-EM structures show one bypass binding mode at both receptors and non-selective Gs activation.
Gu 2026 · PMID 40847076Pathways as reported in the cited laboratory studies, for each compound in the blend. For in-vitro research use only.
05Research history
5 milestones, each linked to its PubMed record
Tesamorelin · Basic & Clinical Pharmacology & Toxicology
The hexenoyl group resists DPP-IV and slows plasma breakdown; repeat runs raise GH and IGF-1 in laboratory models.
PubMed · PMID 17214611Tesamorelin · Expert Opinion on Investigational Drugs
A review traces how tesamorelin was developed as a synthetic analog of human growth hormone releasing factor.
PubMed · PMID 19243281Cagri · The Journal of Pharmacology and Experimental Therapeutics
AM833 (cagri), a lipidated amylin analog, is profiled across 25 endpoints as a nonselective amylin and calcitonin receptor agonist.
PubMed · PMID 33727283GLP-3 RT · STAR Protocols
A protocol to grow human fat cells from preadipocytes and measure lipolysis induced by GLP-3 RT or GIP.
PubMed · PMID 37178114GLP-3 RT · Endocrine
In a diabetic kidney disease model it lowered NLRP3, caspase-1 and TNF-alpha, plus fibronectin, alpha-SMA and collagen I.
PubMed · PMID 39212900 LatestLaboratory research only, cited for research context. Not a claim about use in people.
06Questions
About GLP-3 / Tesa / Cagri, its certificate and your order.
Email [email protected], Monday to Friday. A person replies within one business day.
The current released lot, SA-GL1-2610. Scan the QR code on the vial label to open its certificate. The lot number is also on your packing slip, and the full certificate is here.
Every certificate is issued by an independent laboratory. Each lot has its own public record page with every assay value, and a link to verify the report on the lab's own site once the signed PDF is posted.
Vials are filled slightly over the labelled mass so that every vial meets it. Net content is measured on each lot and published as a number, not a pass.
Email [email protected] within 7 days with your order number and a photo and we will replace it.
Orders by 2 PM ET on a weekday ship the same day, with tracking emailed when the label prints.
No. It is sold strictly for in-vitro laboratory research and is not for human or animal use of any kind.
07Complete the box
3+ vials 25% off and 5+ vials 30% off across any mix, 10+ of one compound 40% off, 50+ of one compound 50% off.
Researcher verification
Smart Amino supplies compounds for in-vitro laboratory research. Before you enter, please confirm three things.
Your confirmation is remembered on this device
